Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/10/1995US5457091 N1-substituted 1H-1,2,3-triazolo[4,5,-D]pyrimidines, a process for their preparation and their use as antiviral agents
10/10/1995US5457055 Diagnostic method for cobalamin deficiency
10/10/1995US5457034 Vectors for expression of NGF in eukaryotic cells
10/10/1995US5456925 Salt of ranitidine and complex of bismuth and tartaric or citric acid with alkaline salt; improved disintegration or dissolution
10/10/1995US5456918 Ranitidine pharmaceutical compositions
10/10/1995US5456912 Non-methylene interrupted fatty acids as immunomodulators
10/10/1995US5456908 Inhibiting cellular uptake of polyamines by contacting cells with transport inhibitory amount of polymer or copolymer of said polyamines
10/10/1995US5456904 Photoprotection compositions comprising certain chelating agents
10/10/1995US5456851 Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole
10/10/1995CA2042032C Therapeutic agent and method of inhibiting vascularization of tumors
10/10/1995CA1337297C Aminoacylates of glycerol acetal
10/10/1995CA1337295C Dihydropyridine derivatives and their preparation and pharmaceutical formulation
10/10/1995CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions
10/10/1995CA1337276C Anticoccidial composition
10/10/1995CA1337272C Drug adsorbates
10/09/1995CA2146600A1 Products with antiglucocorticoid activity used for preparing drugs intended for the prevention or the treatment of manifestations caused by a spontaneous or a precipitated withdrawal symptom due to narcotics or mixtures of narcotics; compositions containing the same
10/06/1995CA2145968A1 Topical antipruritic composition
10/06/1995CA2144783A1 Mdr resistance treatment
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026358A1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them
10/05/1995WO1995026352A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026351A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026350A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same
10/05/1995WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026347A1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents
10/05/1995WO1995026346A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
10/05/1995WO1995026344A1 Sesquiterpenic derivatives
10/05/1995WO1995026342A1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026341A1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
10/05/1995WO1995026339A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
10/05/1995WO1995026338A1 Neurokinin receptor antagonists
10/05/1995WO1995026337A1 Novel carbamates and ureas as modifiers of multi-drug resistance
10/05/1995WO1995026335A1 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their preparation and pharmaceutical compositions containing same
10/05/1995WO1995026334A1 Substituted azetidinone compounds useful as hypocholesterolemic agents
10/05/1995WO1995026328A1 Biphenyl derivatives as 5ht1d antagonists
10/05/1995WO1995026327A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
10/05/1995WO1995026325A2 Enhancement of the efficacy of drugs by deuteration
10/05/1995WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995WO1995026197A1 Adhesion inhibiting composition
10/05/1995WO1995026194A1 Allantoin-metal complexes for skin and hair
10/05/1995WO1995026193A1 Use of hyaluronic acid and forms to prevent arterial restenosis
10/05/1995WO1995026192A1 Starch-metal complexes for skin and hair
10/05/1995WO1995026191A1 Injectable solutions of dirithromycin
10/05/1995WO1995026189A1 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS[(2-AMINOETHYL)AMINO]BENZO[g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT
10/05/1995WO1995026188A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
10/05/1995WO1995026187A1 Anxiolytic agent
10/05/1995WO1995026186A1 Methods of administering n-substituted benzamides or phenothiazines
10/05/1995WO1995026182A1 Active substances and compositions for the therapy of senile xerosis
10/05/1995WO1995026181A1 Substances, combinations of active substances and compositions against skin ageing
10/05/1995WO1995026180A1 Skin care product
10/05/1995WO1995026135A1 Method of treating muscle disease
10/05/1995WO1995026134A1 Composition for inactivating irritants in fluids
10/05/1995WO1995021611A3 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
10/05/1995WO1995018618A3 Enteral formula with ribo-nucleotides
10/05/1995WO1995016452A3 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
10/05/1995DE4411585A1 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption A pharmaceutical combination hormonal contraception
10/05/1995DE4411402A1 DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen DNA expression vectors for use in gene therapy of vascular diseases
10/05/1995DE4411235A1 Thiazolylpyrazolinone Thiazolylpyrazolinone
10/05/1995DE4411225A1 Verwendung von Carbonsäurederivaten als Arzneimittel The use of carboxylic acid derivatives as medicaments
10/05/1995DE4411101A1 Verfahren zur Herstellung eines D-(+)-Biotin-Zwischenproduktes A method for producing a D - (+) - biotin intermediate
10/05/1995CA2186606A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
10/05/1995CA2186448A1 Starch-metal complexes for skin and hair
10/05/1995CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995CA2186389A1 2,4-diphosphonoglutaric acid derivatives, methods of preparing such compounds and drugs containing them
10/05/1995CA2186381A1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents
10/05/1995CA2186377A1 Adhesion inhibiting composition
10/05/1995CA2186371A1 Enhancement of the efficacy of dihydropyridines by deuteration
10/05/1995CA2184754A1 5h-indeno[1,2-b]pyrazine-2,3-dione derivatives, preparation thereof and drugs containing same
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/05/1995CA2182952A1 Methods of administering n-substituted benzamides or phenothiazines
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0675134A1 New 20-amino substituted steroid compounds, a method for their production and intermediates therefor and pharmaceutical compositions containing them
10/04/1995EP0675125A1 A therapeutic agent for thrombocytopenia and indolocarbazole derivatives
10/04/1995EP0675122A2 Mono or bicyclic DNA gyrase inhibitors
10/04/1995EP0675121A1 Novel intermediates and processes for preparing benzothiophene compounds
10/04/1995EP0675120A2 Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
10/04/1995EP0675118A2 Biphenylderivatives, process for their preparation and their use as medicaments
10/04/1995EP0675112A1 Imidazole-containing inhibitors of farnesyl protein transferase
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0675105A1 Polyiodinated compounds, process for their preparation and diagnostic composition
10/04/1995EP0675103A2 Derivatives of essential fatty acids and nonsteroidal antiinflammatory drugs
10/04/1995EP0674904A1 Use of phosphoric acid diester compounds for suppressing hepatic metastases of tumors
10/04/1995EP0674903A1 Raloxifene for inhibiting bone loss and lowing serum cholesterol
10/04/1995EP0674902A1 Method of improving the immune response
10/04/1995EP0674901A1 Transdermal matrix system comprising a styrene-isoprene-styrene copolymer for the administration of an oestrogen and/or gestagen
10/04/1995EP0674900A1 Transdermal matrix system comprising EVA for the administration of an oestrogen and/or gestagen
10/04/1995EP0674716A1 Retroviral vectors for the treatment of tumors, and cell lines containing them
10/04/1995EP0674707A1 Compounds and methods for the treatment of leukemias
10/04/1995EP0674705A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen
10/04/1995EP0674657A1 Gp41 mutants and their use as hiv therapeutics
10/04/1995EP0674651A1 Substituted 6-azaandrostenones
10/04/1995EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/1995EP0674643A1 Coumarin derivatives as retroviral inhibitors
10/04/1995EP0674642A1 Pyrazolopyrimidines as crf antagonists
10/04/1995EP0674641A1 Pyrrolopyrimidines as crf antagonists
10/04/1995EP0674640A1 2-(2-substituted pyrrolidin-4-yl)thio-carbapenem derivatives
10/04/1995EP0674639A1 Azanoradamantanes
10/04/1995EP0674638A1 Substituted triols
10/04/1995EP0674637A1 Quinuclidine derivatives as squalene synthase inhibitors
1 ... 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 6996 6997 6998 ... 7860